1. VUMERITY (diroximel fumarate) delayed-release capsules, for oral use [prescribing information]. Cambridge: Biogen Inc.; 2023.
2. European Medicines Agency. Vumerity summary of product characteristics. 2022. https://www.ema.europa.eu/en/documents/product-information/vumerity-epar-product-information_en.pdf. Accessed 5 Jul 2022.
3. AUBAGIO (teriflunomide) tablets, for oral use [prescribing information]. Cambridge: Genzyme Corporation; 2022.
4. European Medicines Agency. Ponesimod summary of product characteristics. 2021. https://www.ema.europa.eu/en/documents/product-information/ponvory-epar-product-information_en.pdf. Accessed 5 Jul 2022.
5. PONVORY (ponesimod) tablets, for oral use [prescribing information]. Titusville: Janssen Pharmaceuticals; 2022.